Increased concentrations of prostate-specific antigen in maternal serum from pregnancies affected by fetal Down syndrome

Clinical Chemistry

Volumn 44, Issue 2, 1998, Pages 205-208

  Lambert Messerlian, Geralyn M ^a   Canick, Jacob A ^a   Melegos, Dimitrios N ^b   Diamandis, Eleftherios P ^b,c  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FLUOROMETRY; HUMAN; MATERNAL SERUM; PREGNANCY; PRENATAL SCREENING;

EID: 0031884960     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.2.205     Document Type: Article

References (21)

1. Mercatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-94.
2. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol 1988; 95:330-3.
3. Bogart MH, Pandia MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987;7:623-30.
4. Macri JN, Kasturi RV, Krantz DA, Cook EJ, Moore ND, Young J, et al. Maternal Down syndrome screening: free β-protein is a more effective marker than human chorionic gonadotropin. Am J Obstet Gynecol 1990;163:1248-53.
5. Wald NJ, Cuckle HS, Densem JW, Nancnahal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy. Br Med J 1988;297:883-7.
6. Wald NJ, Densem JW, Smith D, Klee GG. Four-marker serum screening for Down's syndrome. Prenat Diagn 1994;14:707-16.
7. Wald NJ, Densem JW, George S, Muttukrisna S, Knight PG. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 1996;16:143-53.
8. Aitken DA, Wallace EM, Crossley J, Swanston IA, Pareren Y, Maarle M, et al. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. N Engl J Med 1996;334:1231-6.
9. Armbruster DA. Prostate-specific antigen: biochemistry, analytical methods, and clinical application [Review]. Clin Chem 1993;39: 181-95.
10. Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP. Ultra-sensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite (immunochemiluminescent) third-generation assay: potential applications in prostate and breast cancers. Clin Chem 1996;42:675-84.
11. Melegos DN, Yu H, Ashok M, Wang C, Stanczyk F, Diamandis EP. Prostate-specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab 1997;82:777-80.
12. Diamandis EP, Yu H. New biological functions of prostate specific antigen? J Clin Endocrinol Metab 1995;80:1515-7.
13. Melegos DN, Yu H, Allen L, Diamandis EP. Prostate specific antigen in amniotic fluid of normal and abnormal pregnancies. Clin Biochem 1996;29:555-62.
14. Yu H, Diamandis EP. Prostate-specific antigen immunoreactivity in amniotic fluid. Clin Chem 1995;41:204-10.
15. Kamoshida S, Tsutsumi Y. Extraprostatic localization of prostate acid phosphatase and prostate-specific antigen: distribution in cloacogenic glandular epithelium and sex-dependent expression in human anal gland. Hum Pathol 1990;21:1108-11.
16. Frazier HA, Humphrey PA, Burchette JL, Paulson DF. Immunoreactive prostate specific antigen in male periurethral glands. J Urol 1992;147:246-8.
17. Iwakiri J, Grandbois K, Wehner N, Graves HCB, Stamey T. An analysis of urinary prostatic specific antigen before and after radical prostectomy: evidence for secretion of prostate specific antigen by the periurethral glands. J Urol 1993;149:783-6.
18. Yu H, Diamandis EP. Prostate-specific antigen in the milk of lactating women. Clin Chem 1995;41:54-60.
19. Canick JA, Rish S. The accuracy of assigned risks in maternal serum screening. Prenat Diagn 1997;(in press).
20. Diamandis EP, Yu H, Sutherland DJA. Detection of prostate specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 1994;32:301-10.
21. Yu H, Diamandis EP, Sutherland DJA. Immunoreactive prostate specific antigen levels in male and female breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 1994;27:75-9.